Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s share price rose 18.2% during mid-day trading on Thursday . The company traded as high as C$0.20 and last traded at C$0.20. Approximately 134,894 shares were traded during trading, a decline of 75% from the average daily volume of 530,731 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Stock Performance
The company has a market cap of C$25.10 million, a price-to-earnings ratio of -18.00 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The firm has a fifty day simple moving average of C$0.11 and a 200 day simple moving average of C$0.08.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- How to Find Undervalued Stocks
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- Using the MarketBeat Dividend Yield Calculator
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
